Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis.

The choice of antithrombotic strategy in this context is challenging and requires tailored decision making with careful consideration of bleeding, thrombotic and ischemic risk for each patient. As the risk of thrombosis and bleeding varies from patient to patient, care is moving away from a 'one size fits all' therapy approach toward more individualized antithrombotic treatment.